Kynam Capital Management, LP Caribou Biosciences, Inc. Transaction History
Kynam Capital Management, LP
- $1.19 Billion
- Q1 2025
A detailed history of Kynam Capital Management, LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 3,269,147 shares of CRBU stock, worth $5.66 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
3,269,147
Previous 2,406,147
35.87%
Holding current value
$5.66 Million
Previous $3.83 Million
22.25%
% of portfolio
0.25%
Previous 0.24%
Shares
5 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
46.4MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$7.82 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$4.34 Million0.18% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.35MShares$4.07 Million0.01% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$3.13 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $105M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...